Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,970 DKK | +0.79% | -2.96% | -8.58% |
Apr. 16 | Genmab, Johnson & Johnson Logs Higher Q1 Sales for Blood Cancer Drug | MT |
Apr. 16 | Genmab A/S Announces DARZALEX Sales Results for the First Quarter of 2024 | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.58% | 18.15B | |
-2.48% | 103B | |
+1.84% | 95.28B | |
+1.46% | 22.15B | |
-15.59% | 21.02B | |
-38.74% | 16.73B | |
-13.14% | 16.05B | |
+5.31% | 13.68B | |
+34.86% | 12.17B | |
-23.98% | 8.24B |
- Stock Market
- Equities
- GMAB Stock
- News Genmab A/S
- Transcript : Genmab A/S, ProfoundBio - M&A Call